Search Results

What is the Case for Prescribing Long-Acting Opioids Over Short-Acting Opioids for Patients with Chronic Pain? A Critical Review

Author: Rauck, Richard L.

Source: Pain Practice, Volume 9, Number 6, November/December 2009 , pp. 468-479(12)

Publisher: Blackwell Publishing

Clinical Pharmacology of Tramadol

Authors: Stefan Grond; Armin Sablotzki

Source: Clinical Pharmacokinetics, Volume 43, Number 13, 2004 , pp. 879-923(45)

Publisher: Adis International

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza&unknown;, and a Twice-Daily Controlled-Release Morphine Formulation in Patients with Chronic Moderate-to-Severe Pain

Authors: Portenoy R.K.; Sciberras A.; Eliot L.; Loewen G.; Butler J.; Devane J.

Source: Journal of Pain and Symptom Management, Volume 23, Number 4, April 2002 , pp. 292-300(9)

Publisher: Elsevier

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long-Term Morphine Treatment

Authors: Andersen G.; Christrup L.L.; Sjogren P.; Hansen S.H.; Jensen N.-H.

Source: Journal of Pain and Symptom Management, Volume 23, Number 2, February 2002 , pp. 161-164(4)

Publisher: Elsevier

Sustained Relief of Chronic Pain: Pharmacokinetics of Sustained Release Morphine

Author: Gourlay G.K.

Source: Clinical Pharmacokinetics, Volume 35, Number 3, September 1998 , pp. 173-190(18)

Publisher: Adis International

Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain

Authors: Gourlay G.K.; Cherry D.A.; Onley M.M.; Tordoff S.G.; Conn D.A.; Hood G.M.; Plummer J.L.

Source: Pain, Volume 69, Number 3, February 1997 , pp. 295-302(8)

Publisher: Elsevier